Abstract
OBJECTIVES - The major immediate-early cytomegalovirus enhancer/promoter (MIECMV), widely used in cardiovascular gene therapy, contains several positively regulatory cAMP response elements (CRE). Catecholamine signaling via β-adrenoceptors might increase transgene expression from MIECMV, and if so, β-blockers may have a detrimental effect on the efficacy of clinical cardiovascular gene therapy strategies. METHODS AND RESULTS - Cultured smooth muscle cells were exposed to isoprenaline, atenolol, or propranolol, alone and in combination before infection with adenoviruses expressing β-galactosidase. β-galactosidase expression was assayed 72 hours later. Isoprenaline increased transgene expression from MIECMV up to 8-fold (P
Original language | English |
---|---|
Pages (from-to) | 2267-2274 |
Number of pages | 7 |
Journal | Arteriosclerosis, Thrombosis, and Vascular Biology |
Volume | 26 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2006 |
Keywords
- β-adrenergic receptor blockers
- Catecholamines
- Gene therapy